Application of log-normal parametric model in disability structure to predict metastasis and death due to breast cancer

authors:

avatar Morteza Hajihosseini , avatar Payam Amini , avatar Maryam Shahdoust , avatar Javad Faradmal , * , avatar Majid Sadeghyfar , avatar Abdolazim Sedighi-Pashaki

Koomesh: Vol.18, issue 1; 95-101
published online: September 28, 2016
article type: issue_documents_importer
received: December 06, 2015
accepted: May 01, 2016

how to cite: Hajihosseini M, Amini P, Shahdoust M, Faradmal J , Sadeghyfar M, et al. Application of log-normal parametric model in disability structure to predict metastasis and death due to breast cancer. koomesh. 2016;18(1):e151150. 

Abstract

Introduction: Determining disease progression process and its affecting factors are of the most important issues in controlling the disease. This study aimed to predict the breast cancer progression as well as assessing the relationship between demographical and clinical factors. Materials and Methods: This retrospective cohort study was conducted on 527 Iranian females with breast cancer who underwent surgery, from 1995 to 2013 using checklists. The effect of the factors on death and tumor recurrence was assessed by log-normal model fitted into each transition of illness-death model which were used to investigate the relationship between demographic and clinical factors and survival time. Data analysis was performed using statistical R software version 3.1.1. The significance level of 0.05 was considered. Results: Evaluating the hazard of death without recurrence, the risk of death in patients over 50 years were higher than those under 50 (P=0.01). A tumor size of 2-5 cm was introduced as a death factor in recurrent patients (P=0.01).Age and type of tumor did not impact the hazard. Log-normal distribution was chosen for downtime between steps. Conclusion: Based on the results, age at diagnosis had significant impact on the risk of death before the first recurrence. Tumor size had a significant effect on death after tumor recurrence. In addition, Log-normal and disability models are appropriate tools to identify the factors influencing survival of patients with breast cancer.

References

  • 1.

    Huang Y. Censored regression with the multistate accelerated sojourn times model. J R Stat Soc Series B Stat Methodol 2002; 64: 17-29.

  • 2.

    Putter H, van der Hage J, de Bock GH, Elgalta R, van de Velde CJ. Estimation and Prediction in a MultiState Model for Breast Cancer. Biom J 2006; 48: 366-380.

  • 3.

    Jafari-Koshki T, Schmid VJ, Mahaki B. Trends of breast cancer incidence in Iran during 20042008: a Bayesian space-time model. Asian Pac J Cancer Prev 2014; 15: 1557-1561.

  • 4.

    Gohari MR, Fard Z, Abolghasemi J, Mohammadi M, Mokhtari P. Prognostic factors of metastases in breast cancer patients using the recurrent Andersen-Gill model. Koomesh 2013; 14: 483-489 (Persian).

  • 5.

    Yaghmaei S, BANI HG, GHORBANI R. Survival rate following treatment of primary breast cancer in Semnan, Iran (1991-2002). Koomesh 2008; 9: 111-116. (Persian).

  • 6.

    Faradmal J, Kazemnejad A, Bakhshi R, Hajizadeh E, Gohari MR. Comparing three adjuvant chemotherapy regimes after modified radical mastectomy in breast cancer patients using log-logistic model. Koomesh 2010; 11: Pe279-Pe87 (Persian).

  • 7.

    Akbari ME, Mozaffar M, Heidari A, Zirakzadeh H, Akbari A, Akbari M, Shirazi FH. Recurrence and survival effect in breast conserving surgery: what are the predictive and/or prognostic factors? Iran J Cancer Prev 2011; 4: 49-54.

  • 8.

    Lee ET, Wang JW. Statistical methods for survival data analysis. 4th ed. New York: John Wiley & Sons; 2013.

  • 9.

    Meier-Hirmer C, Schumacher M. Multi-state model for studying an intermediate event using time-dependent covariates: application to breast cancer. BMC Med Res Methodol 2013; 13: 80.

  • 10.

    Hougaard P. Multi-state models: a review. Lifetime Data Anal 1999; 5: 239-64.

  • 11.

    Andersen PK. Multistate models in survival analysis: a study of nephropathy and mortality in diabetes. Stat Med 1988; 7: 661-670.

  • 12.

    Bhattacharyya M, Klein JP. A random effects model for multistate survival analysis with application to bone marrow transplants. Math Biosci 2005; 194: 37-48.

  • 13.

    Frydman H, Szarek M. Estimation of overall survival in an illnessdeathmodel with application to the vertical transmission of HIV1. Stat Med 2010; 29: 2045-2054.

  • 14.

    Putter H, Fiocco M, Geskus R. Tutorial in biostatistics: competing risks and multistate models. Stat Med 2007; 26: 2389-2430.

  • 15.

    Tsuji W, Teramukai S, Ueno M, Toi M, Inamoto T. Prognostic factors for survival after first recurrence in breast cancer: a retrospective analysis of 252 recurrent cases at a single institution. Breast Cancer 2014; 21: 86-95.

  • 16.

    Egner JR. AJCC cancer staging manual. JAMA 2010; 304: 1726-1727.

  • 17.

    Faradmal J, Mafi M, Sadighi-Pashaki A, Karami M, Roshanaei G. Factors Affecting Survival in Breast Cancer Patients Referred to the Darol Aitam-e Mahdieh Center. ZUMS J 2014; 22: 105-115 (Persian).

  • 18.

    Agresti A. Categorical data analysis. 3rd ed. New York: John Wiley & Sons; 2014.

  • 19.

    R Core Team. R: A language and environment for statistical computing. vienna, austria: R foundation for statistical computing; 2014.

  • 20.

    Royston P. The lognormal distribution as a model for survival time in cancer, with an emphasis on prognostic factors. Stat Neerl 2001; 55: 89-104.

  • 21.

    Kim M-J, Ro JY, Ahn S-H, Kim HH, Kim S-B, Gong G. Clinicopathologic significance of the basal-like subtype of breast cancer: a comparison with hormone receptor and Her2/neu-overexpressing phenotypes. Hum Pathol 2006; 37: 1217-1226.

  • 22.

    Xue C, Wang X, Peng R, Shi Y, Qin T, Liu D, et al. Distribution, clinicopathologic features and survival of breast cancer subtypes in Southern China. Cancer Sci 2012; 103: 1679-1687.

  • 23.

    Society AC. Breast cancer facts and figures 20112012. Am Cancer Society Atlanta GA; 2011.

  • 24.

    Gao N, Xu H, Liu C, Xu H, Chen G, Wang X, Li Y, Wang Y. Nestin: predicting specific survival factors for breast cancer. Tumour Biol 2014; 35: 1751-1755.

  • 25.

    Fallahzadeh H, Momayyezi M, Akhundzardeini R, Zarezardeini S. Five year survival of women with breast cancer in Yazd. Asian Pac J Cancer Prev 2014; 15: 6597-6601.

  • 26.

    de Bock GH, Putter H, Bonnema J, van der Hage JA, Bartelink H, van de Velde CJ. The impact of loco-regional recurrences on metastatic progression in early-stage breast cancer: a multistate model. Breast Cancer Res Trea 2009; 117: 401-408.##.